Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberté(R) drug-eluting stent
Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberté(R) drug-eluting stent
Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberté(R) drug-eluting stent
Submitted by
admin
on October 11, 2008 - 12:01pm
Source:
CNW Telbec
Headline:
Angiotech's corporate partner, Boston Scientific, announces FDA approval of second-generation TAXUS(R) Liberté(R) drug-eluting stent
Do Not Allow Advertisers to Use My Personal information
